Phase 1 Study of C.001 in Retinal Degeneration

NCT07594236 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Geographic Atrophy
Stargardt Disease
RPE-mediated Maculopathy
Age Related Macular Degeneration

Interventions

BIOLOGICAL: Injection

Sponsor

Cellio Therapeutics Inc

Collaborators

[object Object]